| NFKBIE |
Homo sapiens |
|
NFKBIE is differentially expressed in 104 experiments [92 up/92 dn]: 19 organism parts: kidney [0 up/2 dn], primary gastric tumor [1 up/0 dn], ...; 22 disease states: normal [3 up/11 dn], chronic lymphocytic leukemia [1 up/1 dn], ...; 25 cell types, 21 cell lines, 27 compound treatments and 15 other conditions. |
| IKBE, NFKBIE, RP1-302G2.2-003 |
|
Nfkbie (Mus musculus)
cact (Drosophila melanogaster)
Slc35b2 (Rattus norvegicus)
(Compare orthologs)
|
|
|
| Ankyrin repeat, Ankyrin repeat-containing domain |
|
|
| D-serine transport, Golgi apparatus, cytoplasmic sequestering of transcription factor, perinuclear region of cytoplasm, protein binding |
|
|
|
O00221
Q5T9W0
Q7LC14
Q96F31
|
|
|
|
ENSG00000146232
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
None
|
Compound treatment |
|
|
FLAP
|
Compound treatment |
|
|
Kidney
|
Organism part |
|
|
MK886
|
Compound treatment |
|
|
HNRPA2B
|
Compound treatment |
|
|
ERalpha transfected
|
Genotype |
|
|
Control
|
Compound treatment |
|
|
Estrogen receptor 1 negative; ...
|
Test result |
|
|
Chronic lymphocytic leukemia
|
Disease state |
|
|
Huntington's disease
|
Disease state |
|
|
SW480
|
Cell line |
|
|
SW620
|
Cell line |
|
|
Circulating neutrophil
|
Cell type |
|
|
Primary gastric tumor
|
Organism part |
|
|
Fetal bovine serum in media
|
Growth condition |
|
|
Unknown_sex
|
Sex |
|
|
IgV status unknown
|
Genotype |
|
|
In vitro neutrophil
|
Cell type |
|
|
Caudate nucleus
|
Organism part |
|
|
Left temporal parietal
|
Organism part |
|
|
Skin
|
Organism part |
|
|
ITS medium
|
Growth condition |
|
|
ITS medium with albumin-bound ...
|
Growth condition |
|
|
Postprandial lipid micelles in...
|
Growth condition |
|
|
Inter-prandial lipid micelles ...
|
Growth condition |
|
|
ERbeta transfected
|
Genotype |
|
|
Cerebellum
|
Organism part |
|
|
Iloprost
|
Compound treatment |
|
|
Fibroblast
|
Cell type |
|
|
Endothelial cell
|
Cell type |
|
|
Malignant melanoma
|
Disease state |
|
|
IgV unmutated
|
Genotype |
|
|
Female
|
Sex |
|
|
Alveolar space neutrophil
|
Cell type |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
M1 macrophage
|
Cell type |
|
|
Male
|
Sex |
|
|
Peripheral blood
|
Organism part |
|
|
IgV mutated
|
Genotype |
|
|
Kaposi's sarcoma-associated he...
|
Infection |
|
|
Epithelial cell
|
Cell type |
|
|
Stromal cell
|
Cell type |
|
|
Interferon-gamma + lipopolysac...
|
Compound treatment |
|
|
M-CSF
|
Compound treatment |
|
|
Chondrocyte
|
Cell type |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Acute lymphocytic leukemia
|
Disease state |
|
|
BJAB
|
Cell line |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
Spermatocyte
|
Cell type |
|
|
Testis
|
Organism part |
|
|
Monocyte at intermediate diffe...
|
Cell type |
|
|
Epidermal keratinocyte
|
Cell type |
|
|
SkinEthic keratinocyte
|
Cell type |
|
|
Trichostatin A
|
Compound treatment |
|
|
Sporadic basal-like breast can...
|
Disease state |
|
|
Teratozoospermia
|
Disease state |
|
|
Normospermic
|
Disease state |
|
|
Spermatid
|
Cell type |
|
|
Stage II
|
Disease staging |
|
|
MDA468
|
Cell line |
|
|
T cell
|
Cell type |
|
|
Peripheral blood mononuclear c...
|
Cell type |
|
|
Met5A
|
Cell line |
|
|
ERalpha/beta transfected
|
Genotype |
|
|
Cartilage
|
Organism part |
|
|
Skeletal muscle
|
Organism part |
|
|
5-aza-2'-deoxycytidine
|
Compound treatment |
|
|
Seminiferous tubule
|
Organism part |
|
|
Cadmium chloride 2.5-hydrate
|
Compound treatment |
|
|
Baseline uninfected
|
Disease state |
|
|
U87
|
Cell line |
|
|
U373
|
Cell line |
|
|
Monocyte
|
Cell type |
|
|
GLI72
|
Cell line |
|
|
Smooth muscle
|
Organism part |
|
|
ATM knockdown
|
RNAi |
|
|
Macrophage
|
Cell type |
|
|
Arsenic oxide
|
Compound treatment |
|
|
Pseudomonas aeruginosa
|
Infection |
|
|
X-linked chronic granulomatous
|
Disease state |
|
|
BCKN-1
|
Cell line |
|
|
LacZ control
|
RNAi |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
Papillary thyroid carcinoma
|
Disease state |
|
|
A549
|
Cell line |
|
|
Affymetrix Labeling
|
Protocol type |
|
|
Vanadium pentoxide
|
Compound treatment |
|
|
Superior cervical ganglion
|
Organism part |
|
|
Heat-killed HL60 cell lysate
|
Infection |
|
|
17-allylamino-geldanamycin
|
Compound treatment |
|
|
White blood cell
|
Cell type |
|
|
Platelet
|
Cell type |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
293
|
Cell line |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
Blood
|
Organism part |
|
|
Tonsil
|
Organism part |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
Experimental malaria-infected
|
Disease state |
|
|
BL41K3
|
Cell line |
|
|
BJABK3
|
Cell line |
|
|
Tissue culture polystyrene dis...
|
Growth condition |
|
|
Collagen/chondroitin tissue en...
|
Growth condition |
|
|
HaCaT
|
Cell line |
|
|
Johnsen score count 3.2: Serto...
|
Histology |
|
|
PEL-5
|
Cell line |
|
|
Benign nevi
|
Disease state |
|
|
Spleen
|
Organism part |
|
|
Enzo Labeling
|
Protocol type |
|
|
Breast carcinoma
|
Disease state |
|
|
SKMEL5
|
Cell line |
|
|
N/a
|
Test result |
|
|
None
|
Infection |
|
|
Stage IIIc/2
|
Disease staging |
|
|
Adult
|
Developmental stage |
|
|
Infant
|
Developmental stage |
|
|
Gastric cancer
|
Disease state |
|
|
Naive CD4 T cell
|
Target cell type |
|
|
Infrared light
|
Light |
|
|
Differentiated
|
Cell type |
|
|
Naive
|
Cell type |
|
|
Homo sapiens
|
Organism |
|
|
Capra hircus
|
Organism |
|
|
Methotrexate
|
Compound treatment |
|
|
Phenol
|
Compound treatment |
|
|
Propofol
|
Compound treatment |
|
|
Phorbol 12-myristate 13-acetat...
|
Compound treatment |
|
|
Down syndrome
|
Disease state |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
Endometrioid carcinoma
|
Disease state |
|
|
Macaca mulatta
|
Organism |
|
|
Doxycycline
|
Compound treatment |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
U937
|
Cell line |
|
|
Tumor necrosis factor
|
Compound treatment |
|
|
Relapse 0; ER status ER-; brai...
|
Clinical info |
|
|
White blood cells
|
Organism part |
|
|
HPL1
|
Cell line |
|
|
BT474
|
Cell line |
|
|
KSHV-negative EBV-positive
|
Clinical info |
|
|
Oligomycin
|
Compound treatment |
|
|
GLI60
|
Cell line |
|
|
T3aN0Mx
|
Disease staging |
|
|
Not applicable
|
Histology |
|
|
Sulmazole
|
Compound treatment |
|
|
Baseline sevoflurane
|
Compound treatment |
|
|
GLI56
|
Cell line |
|
|
Esophageal adenocarcinoma
|
Disease state |
|
|
Obesity
|
Disease state |
|
|
BDCA1+ dendritic cell
|
Cell type |
|
|
Heat-killed Anaplasma phagocyt...
|
Infection |
|
|
4OH-tamoxifen
|
Compound treatment |
|
|
IL-4
|
Compound treatment |
|
|
Staphylococcus aureus
|
Infection |
|
|
Monoclonal gammopathy of undet...
|
Disease state |
|
|
|
|
|
Processing time: 0.122 secs.